Found 15 dm-gastroenterology trials
A listing of dm-gastroenterology medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
To investigate the safety and efficacy of Tradipitant versus placebo in relieving nausea and other symptoms of gastroparesis.
This study is not open to participants that have not completed the induction study. This treatment plan is for a single patient with gastroparesis who has requested expanded access to tradipitant. Gastroparesis is a condition where the stomach is unable to perform its normal functions. Individuals with gastroparesis have delayed …
Are you still experiencing celiac disease symptoms despite your best efforts to follow a gluten-free diet?The goal of this phase 2 clinical trial is to test the safety and effects of the investigational medication PRV-015. In combination with a gluten-free diet, PRV-015 aims to reduce symptoms and intestinal inflammation caused …
Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes in many countries. Participants will need to inject themselves with medicine under the skin. Participants will need to do this once a week. The study …
The Revitalize-1 Study will look at a potential procedure called duodenal mucosal resurfacing (DMR). The DMR procedure acts on the first layer (mucosa) of the duodenum (the part of the small intestine located immediately after the stomach). By removing an excess layer, the treatment may improve blood sugar control. This …
The main purpose of this study is to see if an experimental drug, TRADIPITANT can help people with diabetic or idiopathic gastroparesis who are suffering from nausea.
Are you between the ages of 18-70? Do you have an ileostomy? You may be eligible for this study!
The purpose of this study is to find out if the investigational drug, apraglutide and investigational drug , is able to reduce the volume per week of PS required in adults with short bowel syndrome and intestinal failure.
Approximately 50% of patients with celiac disease have continued symptoms despite at least 12 months of treatment with a gluten free diet. PRV-015, a mAb that blocks IL-15, has been shown to reduce intestinal inflammation and improve clinical symptoms induced by gluten consumption in a previous Phase 2a gluten-challenge study …
The primary purposes of this research study is to determine the safety and tolerability of the investigational drug, XmAb18087, and if the XmAb18087 works in treating tumors like you have and side effects from XmAb18087, to find the best dose for treating your type of tumor. XmAb18087 is an investigational …
1 - 10 of 15
- 1
- 2
